Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients.
AuthorsHashem, Anwar M
Almahboub, Sarah A
Alfaleh, Mohamed A
Abujamel, Turki S
Alamri, Sawsan S
Alluhaybi, Khalid A
Hobani, Haya I
AlHarbi, Rahaf H
Alsulaiman, Reem M
Alharbi, Naif K
Alhabbab, Rowa Y
AlSaieedi, Ahdab A
Abdulaal, Wesam H
AL-Somali, Afrah A
Alofi, Fadwa S
Khogeer, Asim A
Alkayyal, Almohanad A
Almontashiri, Naif A M
Ahmad, Bakur Mahmoud
KAUST DepartmentBioscience Program
Biological and Environmental Sciences and Engineering (BESE) Division
Permanent link to this recordhttp://hdl.handle.net/10754/666365
MetadataShow full item record
AbstractThe Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, continues to spread globally with significantly high morbidity and mortality rates. Antigen-specific responses are of unquestionable value for clinical management of COVID-19 patients. Here, we investigated the kinetics of IgM, IgG against the spike (S) and nucleoproteins (N) proteins and their neutralizing capabilities in hospitalized COVID-19 patients with different disease presentations (i.e., mild, moderate or severe), need for intensive care units (ICU) admission or outcomes (i.e., survival vs death). We show that SARS-CoV-2 specific IgG, IgM and neutralizing antibodies (nAbs) were readily detectable in almost all COVID-19 patients with various clinical presentations. Interestingly, significantly higher levels of nAbs as well as anti-S1 and -N IgG and IgM antibodies were found in patients with more severe symptoms, patients requiring admission to ICU or those with fatal outcomes. More importantly, early after symptoms onset, we found that the levels of anti-N antibodies correlated strongly with disease severity. Collectively, these findings provide new insights into the kinetics of antibody responses in COVID-19 patients with different disease severity.
CitationHashem, A. M., Algaissi, A., Almahboub, S. A., Alfaleh, M. A., Abujamel, T. S., Alamri, S. S., … Li, X. (2020). Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients. Viruses, 12(12), 1390. doi:10.3390/v12121390
SponsorsThe authors extend their appreciation to the Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia for funding this research.
Except where otherwise noted, this item's license is described as This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
- Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
- Authors: Rostad CA, Chahroudi A, Mantus G, Lapp SA, Teherani M, Macoy L, Tarquinio KM, Basu RK, Kao C, Linam WM, Zimmerman MG, Shi PY, Menachery VD, Oster ME, Edupuganti S, Anderson EJ, Suthar MS, Wrammert J, Jaggi P
- Issue date: 2020 Dec
- Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.
- Authors: Feng X, Yin J, Zhang J, Hu Y, Ouyang Y, Qiao S, Zhao H, Zhang T, Li X, Zhang L, Zhang J, Jin R, Feng Y, Su B
- Issue date: 2021
- Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.
- Authors: Mariën J, Ceulemans A, Michiels J, Heyndrickx L, Kerkhof K, Foque N, Widdowson MA, Mortgat L, Duysburgh E, Desombere I, Jansens H, Van Esbroeck M, Ariën KK
- Issue date: 2021 Feb
- Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset.
- Authors: Xiang T, Liang B, Fang Y, Lu S, Li S, Wang H, Li H, Yang X, Shen S, Zhu B, Wang B, Wu J, Liu J, Lu M, Yang D, Dittmer U, Trilling M, Deng F, Zheng X
- Issue date: 2021
- The kinetics of humoral response and its relationship with the disease severity in COVID-19.
- Authors: Ren L, Zhang L, Chang, Wang J, Hu Y, Chen H, Guo L, Wu C, Wang C, Wang Y, Wang Y, Wang G, Yang S, Dela Cruz CS, Sharma L, Wang L, Zhang D, Wang J
- Issue date: 2020 Dec 11